Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Clin Endosc > Volume 53(5); 2020 > Article
Original Article Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis
Pradeep Kumar Siddappa1,orcid, Neha Jain1orcid, Naveen K. Agarwal2orcid, Monika Jain1orcid, Gurwant Singh Lamba1orcid
Clinical Endoscopy 2020;53(5):594-599.
DOI: https://doi.org/10.5946/ce.2019.175
Published online: September 29, 2020

1Department of Gastroenterology, Sri Balaji Action Medical Institute, New Delhi, India

2Department of Pathology, Action Cancer Hospital, New Delhi, India

Correspondence: Pradeep Kumar Siddappa Current affiliation- Department of Internal Medicine, UCONN Health, 263 Farmington Avenue, Farmington, CT 06030, USA Tel: +1-507-202-4577, Fax: +1-860-679-4613, E-mail: dr.pradeep@outlook.com
• Received: September 9, 2019   • Revised: March 20, 2020   • Accepted: April 3, 2020

Copyright © 2020 Korean Society of Gastrointestinal Endoscopy

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 4,564 Views
  • 81 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Scopus
prev next
Full Article

Download PDF Download PDF

  • Background/Aims
    Diagnostic abdominal paracentesis has been described in literature to have variable sensitivity of 50%–75% for the detection of peritoneal carcinomatosis (PC). We believe that random needle aspirates from the omentum, even in the absence of obvious deposits by endoscopic ultrasound (EUS), could prove malignancy in patients with PC.
  • Methods
    Consecutive patients who underwent EUS for diagnosis and staging of cancer and found to have ascites were included after obtaining informed consent. EUS-guided fine needle aspiration (EUS-FNA) from random sites in the omentum was performed through the transgastric route using a linear echoendoscope.
  • Results
    Fifty-four patients underwent EUS during October 2015 to April 2017 for detection, staging, or FNA of a suspected malignant lesion. Ascites was seen in 17 patients and 15 patients who fulfilled the criteria were included. The procedure was successful in all patients. Cytology was suggestive of malignancy in 12 (80%) but not suggestive of malignancy in 3 (20%) patients. Three patients who tested negative had hyperbilirubinemia with biliary obstruction. Their ascitic fluid analysis result was also negative.
  • Conclusions
    Random FNA of the omentum in patients with malignancy-related ascites is highly effective in the diagnosis of PC and could be employed during EUS evaluation of malignancies.
  • Keywords: Ascites; Endoscopic ultrasound; Endoscopic ultrasound-guided fine needle aspiration; Omentum; Peritoneal neoplasms
Diagnostic abdominal paracentesis has been described in literature to have variable sensitivity of 50%–75% for the detection of peritoneal carcinomatosis (PC) in malignancy related ascites [1-3]. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of peritoneal deposits have been shown to detect PC [4]. Detection of metastatic deposits and their aspiration requires a high level of expertise and skill to achieve consistent results. We believe that random EUS guided needle aspirates from the omentum, with or without visible peritoneal deposits on EUS can help diagnose patients with PC. In this pilot study, we aim to show the PC detection rate in patients undergoing EUS-FNA from random sites on the omentum with ascites and proven or suspected malignancy.
This pilot, single arm prospective uncontrolled study, was conducted at a tertiary hospital in New Delhi from October 2015 to April 2017. The study was approved by the institutional ethics committee. Consecutive patients with ascites and known or suspected malignancy, who underwent EUS for staging or FNA, were included after obtaining informed consent. Patients who did not have a vessel free window on EUS for the safe introduction of FNA needle, who needed the needle to traverse the mass/tumor involving the stomach or duodenal wall to reach the omentum were excluded.
Patients were considered to have PC if they had, (1) Cytological analysis of EUS-FNA of the omentum confirming malignant cells or showing cells suspicious of malignancy in the right clinical context, (2) Ascitic fluid cytology positive for malignant cells, (3) Surgical histopathology confirming the presence of peritoneal involvement.
Consenting patients underwent EUS using a liner echoendoscope (GF-UCT180; Olympus, Tokyo, Japan). The procedure was performed under conscious sedation. Ascites has an anechoic appearance on EUS (Fig. 1). Omentum was identified as a frond-like hyperechoic, floating, intraperitoneal structure on EUS evaluation when viewed from the stomach station, in the background of ascites (Fig. 2). A clear and safe path, away from the liver and blood vessels in the space between the stomach wall and the omentum, with intervening ascites, was identified on EUS. EUS-FNA was performed from the omentum through the transgastric route. A 22-gauge (G) or 25 G FNA needle (Expect; Boston Scientific Co., Natick, MA, USA) was used for all the procedures. FNA was only attempted if the needle did not traverse the organ involved in the malignant process. EUS-FNA needle was carefully introduced under the vision to avoid liver and vessels within the omentum (Fig. 3). Rapid quick jabs were required to pierce through the stomach wall and reach the omentum. No aspiration was applied to the FNA needle to ensure that the aspirate was minimally contaminated by ascitic fluid. Smears were made from the material aspirated and sent for analysis (Fig. 4). Two or more passes were taken from random sites on the omentum. We did not have a cytopathologist or a cytotechnologist for assessment of adequacy at the bedside during any of the procedures.
Patients were monitored for 2 hours after the procedure in the endoscopy suite for any complication. Each patient was given a short course of post-procedure oral antibiotic for 3 days. Percutaneous trans-abdominal paracentesis was performed for patients who had negative results on EUS-FNA. Computed tomography (CT) or magnetic resonance imaging findings of the involvement of the omentum were recorded for each patient. EUS-FNA results showing the presence of malignant cells or smears suspicious for malignancy were considered diagnostic of PC in the right clinical context.
Statistical analysis
Categorical variables were expressed as frequency (%) and continuous variable were reported as median (range).
Fifty-four patients underwent EUS during the study period for detection, staging or FNA of the malignant lesion. Ascites was seen in 17 patients. Two patients who refused FNA were excluded. Eventually, 15 patients who fulfilled the criteria were included (Table 1). The median age of the patients was 64 (range, 33–80) years and 11 (73.3%) of them were females. Cross-sectional imaging was performed before the EUS in all the patients. Ascites was noted on cross-sectional imaging in all 15 patients. Peritoneal or omental involvement was noted on cross-sectional imaging in 6 (40%) patients, while no peritoneal or omental involvement was seen in 9 (60%). Peritoneal deposits/nodules were noted in 2 (13.3%), omental thickening was seen in 2 (13.3%), omental deposits are seen in 1 (6.6%), and omental stranding was noted in 1 patient (6.6%) (Table 1). The indications for EUS were: the evaluation of ascites in 11 patients (73.3%), pancreatic ductal adenocarcinoma in 1 patient (6.6%), and evaluation of obstructive jaundice in 3 patients (20.1%).
Omental deposits were identified on EUS in 2 patients. In the rest of patients, omentum was identified without any obvious abnormality. All the patients underwent EUS-FNA of the omentum through the transgastric route. Adequate tissue was obtained in all the patients. Patients underwent a median of 3 passes (range, 2–5) from the omentum. None of the patients underwent EUS guided trans-gastric ascitic fluid aspiration. Omental tissue appeared as translucent bits of tissue on the slide after transfer from the FNA needle.
Cytology was suggestive of malignancy in 12 patients (80%) and not suggestive of malignancy in 3 (20%). The final report was positive for malignancy in 10, suspicious in 2, and negative in 3 patients. Immunohistochemistry was performed and identified adenocarcinoma in 6 and was not performed in the rest. Primary malignancy was ovarian in 4 patients, gall bladder in 3 patients, unknown primary in 1 patient, and cholangiocarcinoma in 2 patients (Table 1).
The three patients with negative results had high-grade common bile duct obstruction with total bilirubin levels of 299.25 µmol/L, 244.5 µmol/L, and 273.6 µmol/L at the time of the procedure. Ascitic fluid analysis in these 3 patients showed a serum ascites albumin gradient (SAAG) of more than 11 g/L. They did not have any imaging features of cirrhosis. A final diagnosis of cholangiocarcinoma was made by abdominal wall biopsy of a metastatic lesion and endoscopic retrograde cholangiopancreatography biliary biopsy (Table 1). These three patients were followed for aduration of 90, 50, and 102 days, and none of them were diagnosed with PC. We considered, both, suspicious and positive report of malignancy as being definitive evidence of malignancy. This made the sensitivity and specificity of the procedure to diagnose PC to be 100%. However, if we consider patients with a suspicious report to be false negative, our procedure had a sensitivity, specificity, positive predictive value, and negative predictive value of 83.3%, 100%, 100%, and 60%, respectively.
None of the patients developed any procedure-related adverse events. All the patients completed a 3-day course of antibiotics and none of them developed any signs or symptoms of infection.
Malignancy-related ascites is a broad term for patients who develop ascites due to underlying malignancy. It accounts for less than 7% of cases with ascites [5]. The underlying cause of ascites in patients with malignancy can vary. PC is one of the causes of malignancy-related ascites. The sensitivity of cytology to detect malignant cells in patients with PC in the ascitic fluid is at best 75% [1-3]. Success depends on various factors like the amount of fluid aspirated, quality of the processing service, and the number of samples processed.
Ascitic fluid appears as the anechoic area between the organs. In patients with minimal ascites, fluid can be identified as an anechoic rim around the liver with patients in the left lateral position (Fig. 1). Omentum can be identified as a hyperechoic frond-like floating structure (Fig. 2). However, if the amount of ascites is low, the best position for visualization of ascitic fluid is from the antrum of the stomach. Vessels are easily identified in the omentum and care should be taken not to injure them during aspiration. As omentum is not a fixed structure, aspiration is difficult as the needle slips during the introduction. Furthermore, unlike aspiration of solid structures which are closely abutted by the stomach wall, aspiration of omentum and penetration of the stomach wall can be difficult. To overcome these problems, the needle introduction must be swift to penetrate the stomach wall. Once the needle is in the cavity, omentum can be biopsied by to and fro motion of the needle (Fig. 3). We believe that 25 G or 22 G needles are best suited for this procedure. Translucent tissue is identified on the slide upon successful aspiration of omentum; however, it might not be seen in all the patients.
EUS has been shown to be better than cross-sectional imaging like CT scan for the detection of ascites. In a study by Nguyen et al., 15% of the patients taken up for EUS for gastrointestinal malignancy were noted to have ascites [6]. Ascites was detected in only 18% of these patients on the CT scan [6]. EUS has been used in aspiration of ascitic fluid and in the sampling of peritoneal deposits for diagnosis of PC with success [4,7,8]. In a prospective case series by Kaushik et al., the sensitivity and specificity of EUS aspiration of ascitic fluid for the diagnosis of PC were 94% and 100%, respectively [7]. In a more recent study by Wardeh et al., the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of EUS guided paracentesis in the diagnosis of PC were 80%, 100%, 100%, 95%, and 96%, respectively [9]. Not all studies have been so optimistic. In a retrospective study from Mayo Clinic, Rochester, peritoneal anomalies detected on EUS but not the presence of ascites were suggestive of PC (odds ratio of 2.56). They also found that EUS-FNA of the peritoneum upstaged malignancy in 23.6% of patients [10]. A study by DeWitt et al., concluded that a negative report from cytologic analysis of EUS guided ascitic fluid aspiration does not exclude the diagnosis of malignant ascites [11]. EUS and EUS-FNA is a difficult technique to master [12]. Detection of subtle changes noted on EUS for the visual diagnosis of peritoneal and omental deposits can be difficult even to an experienced endoscopist.
In this pilot study, we showed that EUS-FNA from omentum in patients with malignancy-related ascites can detect PC. We believe that the presence of cancer cells in the ascitic fluid circulates and deposits on the peritoneum, increasing the density of cells in the peritoneum due to constant deposition. In a retrospective surgical series, 7.1% of patients with epithelial ovarian cancer who underwent random peritoneal biopsies from normal-appearing locations during laparotomy were upstaged, and 2.7% of the patients who underwent routine omentectomy were upstaged based on microscopic metastasis over the peritoneum and omentum [13].
The omental EUS-FNA procedure is safe and none of our patients developed any features of significant intra-abdominal bleeding. None of the patients experienced pain or other adverse symptoms post-procedure. Three patients, in whom FNA was negative, may have had another mechanism of ascites. All these patients had high-grade biliary obstruction with hyperbilirubinemia. It has been shown in a mouse study that high-grade biliary obstruction can lead to portal hypertension [14]. This could explain the ascites and high SAAG level in these patients. The limitations of our study were the limited sample size and the fact that not all patients underwent percutaneous ascitic fluid aspiration.
To conclude, EUS guided random biopsy of the omentum in patients suspected of malignant ascites has high sensitivity and specificity for the diagnosis of PC. This procedure can be safely employed during EUS evaluation of malignancies. Further studies comparing this procedure with percutaneous ascitic fluid aspiration and surgical staging should be considered.
Fig. 1.
Endoscopic ultrasound image showing ascites. Ascites visualized as the anechoic area around the liver (arrow).
ce-2019-175f1.jpg
Fig. 2.
Endoscopic ultrasound image showing the omentum. Frond-like omentum in the middle of ascites (anechoic, area) (arrow).
ce-2019-175f2.jpg
Fig. 3.
Endoscopic ultrasound (EUS) image showing EUS needle penetrating the omentum. Fine needle aspiration needle penetrating the omentum (arrow).
ce-2019-175f3.jpg
Fig. 4.
Malignant cells obtained from the needle aspiration of the omentum (hematoxylin-eosin, original magnification ×40).
ce-2019-175f4.jpg
Table 1.
Patient Clinical Characteristics and Results of Endoscopic Ultrasound-Guided Fine Needle Aspiration of the Omentum in Patients with Suspected Malignancy-Related Ascites
Serial number Age/Gender Presenting complaint Crosssectional imaging Cross-sectional imaging findings in the omentum/peritoneum EUS findings Primary site of malignancy/method of diagnosis Result of EUS guided omental sampling
1 66/F Abdominal pain, fever and vomiting CT abdomen No omental/peritoneal involvement Large lymph nodes in the periportal, peripancreatic and celiac nodes. Ascites noted Gall bladder adenocarcinoma/EUS-FNA Positive for malignant cells/adenocarcinoma
2 65/F Distention of abdomen PET CT Peritoneal deposits Massive ascites noted Ovary cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells/adenocarcinoma
3 33/M Distention of abdomen, pain abdomen CT abdomen No omental/peritoneal involvement No omental deposits noted Pancreatic adenocarcinoma/EUS-FNA Positive for malignant cells
4 62/M Distention of abdomen and weight loss CT abdomen Peritoneal nodules Gross ascites noted. No obvious mass lesion or abdominal lymphadenopathy. No omental nodule noted Colon cancer/endoscopic biopsy Positive for malignant cells/adenocarcinoma
5 75/F Distention of abdomen PET CT Omental thickening Ascites without any omental abnormality Endometrium/hysteroscopy and biopsy Positive for malignant cells/adenocarcinoma
6 48/F Jaundice and pain abdomen PET CT No omental/peritoneal involvement No omental abnormality noted Cholangiocarcinoma/FNA from a metastatic abdomen wall lesion No malignant cells noted
7 63/F Distention of abdomen, pain abdomen PET CT Omental thickening Ascites and pleural effusion. No omental abnormality detected Ovarian cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells/adenocarcinoma
8 48/F Distention of abdomen and jaundice CT abdomen No omental/peritoneal involvement Ascites. No omental abnormality noted Cholangiocarcinoma/ERCP biliary brushings No malignant cells noted
9 65/F Distention of abdomen and weight loss CT abdomen Fat stranding of the omentum Ascites with omental deposits Ovarian cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells
10 80/F Distention of abdomen MRI abdomen No omental/peritoneal involvement Ascites without any obvious omental abnormality Gall bladder adenocarcinoma/ultrasound-guided FNA Positive for malignant cells
11 70/M Pain abdomen MRI abdomen No omental/peritoneal involvement Multiple hypoechoic large periportal lymph nodes. Ascites with omental deposits Urinary bladder cancer/cystoscopic biopsy Positive for malignant cells
12 65/M Weight loss PET CT Omental deposits Ascites noted without any significant abnormality in the omentum Unknown primary Suspicious for malignant cells
13 50/F Pain abdomen CT abdomen No omental/peritoneal involvement Mass lesion noted in the Gall bladder fossa with ascites. No obvious abnormality noted in the omentum on EUS Gall bladder cancer/ultrasoundguided FNA Suspicious for malignant cells
14 60/F Distention of abdomen CT abdomen No omental/peritoneal involvement Gross ascites without any obvious abnormality in the omentum Ovarian cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells
15 65/F Obstructive jaundice CT abdomen No omental/peritoneal involvement No obvious abnormality in the omentum Periampullary adenocarcinoma/endoscopic biopsy No malignant cells noted

CA 125, carbohydrate antigen 125; CT, computed tomography; ERCP, endoscopic retrograde cholangiopancreatography; EUS-FNA, endoscopic ultrasound-guided fine needle aspiration; MRI, magnetic resonance imaging; PET, positron emission tomography.

  • 1. Allen VA, Takashima Y, Nayak S, Manahan KJ, Geisler JP. Assessment of false-negative ascites cytology in epithelial ovarian carcinoma: a study of 313 patients. Am J Clin Oncol 2017;40:175–177.ArticlePubMed
  • 2. Decker D, Stratmann H, Springer W, Schwering H, Varnai N, Bollmann R. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis. Pathol Res Pract 1998;194:791–795.ArticlePubMed
  • 3. Kielhorn E, Schofield K, Rimm DL. Use of magnetic enrichment for detection of carcinoma cells in fluid specimens. Cancer 2002;94:205–211.ArticlePubMed
  • 4. Rana SS, Bhasin DK, Srinivasan R, Singh K. Endoscopic ultrasound-guided fine needle aspiration of peritoneal nodules in patients with ascites of unknown cause. Endoscopy 2011;43:1010–1013.ArticlePubMedPDF
  • 5. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992;117:215–220.ArticlePubMed
  • 6. Nguyen PT, Chang KJ. EUS in the detection of ascites and EUS-guided paracentesis. Gastrointest Endosc 2001;54:336–339.ArticlePubMed
  • 7. Kaushik N, Khalid A, Brody D, McGrath K. EUS-guided paracentesis for the diagnosis of malignant ascites. Gastrointest Endosc 2006;64:908–913.ArticlePubMed
  • 8. Peter S, Eltoum I, Eloubeidi MA. EUS-guided FNA of peritoneal carcinomatosis in patients with unknown primary malignancy. Gastrointest Endosc 2009;70:1266–1270.ArticlePubMed
  • 9. Wardeh R, Lee JG, Gu M. Endoscopic ultrasound-guided paracentesis of ascitic fluid: a morphologic study with ultrasonographic correlation. Cancer Cytopathol 2011;119:27–36.ArticlePubMed
  • 10. Levy MJ, Abu Dayyeh BK, Fujii LL, et al. Detection of peritoneal carcinomatosis by EUS fine-needle aspiration: impact on staging and resectability (with videos). Gastrointest Endosc 2015;81:1215–1224.ArticlePubMed
  • 11. DeWitt J, LeBlanc J, McHenry L, McGreevy K, Sherman S. Endoscopic ultrasound-guided fine-needle aspiration of ascites. Clin Gastroenterol Hepatol 2007;5:609–615.ArticlePubMed
  • 12. Wani S, Coté GA, Keswani R, et al. Learning curves for EUS by using cumulative sum analysis: implications for American Society for Gastrointestinal Endoscopy recommendations for training. Gastrointest Endosc 2013;77:558–565.ArticlePubMed
  • 13. Lee JY, Kim HS, Chung HH, Kim JW, Park NH, Song YS. The role of omentectomy and random peritoneal biopsies as part of comprehensive surgical staging in apparent early-stage epithelial ovarian cancer. Ann Surg Oncol 2014;21:2762–2766.ArticlePubMedPDF
  • 14. Franco D, Gigou M, Szekely AM, Bismuth H. Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat. Arch Surg 1979;114:1064–1067.ArticlePubMed

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma
      Abhirup Chatterjee, Jimil Shah
      Diagnostics.2023; 14(1): 78.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis
      Clin Endosc. 2020;53(5):594-599.   Published online September 29, 2020
      DOI: https://doi.org/10.5946/ce.2019.175
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    • 3
    Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis
    Image Image Image Image
    Fig. 1. Endoscopic ultrasound image showing ascites. Ascites visualized as the anechoic area around the liver (arrow).
    Fig. 2. Endoscopic ultrasound image showing the omentum. Frond-like omentum in the middle of ascites (anechoic, area) (arrow).
    Fig. 3. Endoscopic ultrasound (EUS) image showing EUS needle penetrating the omentum. Fine needle aspiration needle penetrating the omentum (arrow).
    Fig. 4. Malignant cells obtained from the needle aspiration of the omentum (hematoxylin-eosin, original magnification ×40).

    Fig. 1.

    Fig. 2.

    Fig. 3.

    Fig. 4.

    Endoscopic Ultrasound-Guided Random Omental Fine Needle Aspiration: A Novel Technique for the Diagnosis of Peritoneal Carcinomatosis
    Serial number Age/Gender Presenting complaint Crosssectional imaging Cross-sectional imaging findings in the omentum/peritoneum EUS findings Primary site of malignancy/method of diagnosis Result of EUS guided omental sampling
    1 66/F Abdominal pain, fever and vomiting CT abdomen No omental/peritoneal involvement Large lymph nodes in the periportal, peripancreatic and celiac nodes. Ascites noted Gall bladder adenocarcinoma/EUS-FNA Positive for malignant cells/adenocarcinoma
    2 65/F Distention of abdomen PET CT Peritoneal deposits Massive ascites noted Ovary cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells/adenocarcinoma
    3 33/M Distention of abdomen, pain abdomen CT abdomen No omental/peritoneal involvement No omental deposits noted Pancreatic adenocarcinoma/EUS-FNA Positive for malignant cells
    4 62/M Distention of abdomen and weight loss CT abdomen Peritoneal nodules Gross ascites noted. No obvious mass lesion or abdominal lymphadenopathy. No omental nodule noted Colon cancer/endoscopic biopsy Positive for malignant cells/adenocarcinoma
    5 75/F Distention of abdomen PET CT Omental thickening Ascites without any omental abnormality Endometrium/hysteroscopy and biopsy Positive for malignant cells/adenocarcinoma
    6 48/F Jaundice and pain abdomen PET CT No omental/peritoneal involvement No omental abnormality noted Cholangiocarcinoma/FNA from a metastatic abdomen wall lesion No malignant cells noted
    7 63/F Distention of abdomen, pain abdomen PET CT Omental thickening Ascites and pleural effusion. No omental abnormality detected Ovarian cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells/adenocarcinoma
    8 48/F Distention of abdomen and jaundice CT abdomen No omental/peritoneal involvement Ascites. No omental abnormality noted Cholangiocarcinoma/ERCP biliary brushings No malignant cells noted
    9 65/F Distention of abdomen and weight loss CT abdomen Fat stranding of the omentum Ascites with omental deposits Ovarian cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells
    10 80/F Distention of abdomen MRI abdomen No omental/peritoneal involvement Ascites without any obvious omental abnormality Gall bladder adenocarcinoma/ultrasound-guided FNA Positive for malignant cells
    11 70/M Pain abdomen MRI abdomen No omental/peritoneal involvement Multiple hypoechoic large periportal lymph nodes. Ascites with omental deposits Urinary bladder cancer/cystoscopic biopsy Positive for malignant cells
    12 65/M Weight loss PET CT Omental deposits Ascites noted without any significant abnormality in the omentum Unknown primary Suspicious for malignant cells
    13 50/F Pain abdomen CT abdomen No omental/peritoneal involvement Mass lesion noted in the Gall bladder fossa with ascites. No obvious abnormality noted in the omentum on EUS Gall bladder cancer/ultrasoundguided FNA Suspicious for malignant cells
    14 60/F Distention of abdomen CT abdomen No omental/peritoneal involvement Gross ascites without any obvious abnormality in the omentum Ovarian cancer/ovarian mass on imaging with elevated serum CA 125 Positive for malignant cells
    15 65/F Obstructive jaundice CT abdomen No omental/peritoneal involvement No obvious abnormality in the omentum Periampullary adenocarcinoma/endoscopic biopsy No malignant cells noted
    Table 1. Patient Clinical Characteristics and Results of Endoscopic Ultrasound-Guided Fine Needle Aspiration of the Omentum in Patients with Suspected Malignancy-Related Ascites

    CA 125, carbohydrate antigen 125; CT, computed tomography; ERCP, endoscopic retrograde cholangiopancreatography; EUS-FNA, endoscopic ultrasound-guided fine needle aspiration; MRI, magnetic resonance imaging; PET, positron emission tomography.

    Table 1.

    Clin Endosc : Clinical Endoscopy Twitter Facebook
    © Korean Society of Gastrointestinal Endoscopy.
    Close layer
    TOP